Drug Database
Back to search

Canada· CA-DIN-02439611

HUMALOG 200 UNITS/ML KWIKPEN

A insulin lispro product containing insulin lispro, registered in Canada by ELI LILLY CANADA INC. The same ATC class is registered in 11 of our 19 countries.

ATC A10AB04

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedHUMALOG 200 UNITS/ML KWIKPENATCA10AB04REGISTER NO.CA-DIN-02439611PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insulin lisproAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin lispro is registered in 11 of 19 countries.

Countries holding a registration under ATC A10AB04 (insulin lispro), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search insulin lispro products by name

Insulin lispro · ATC A10AB04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
INSULIN LISPRO
Manufacturer
ELI LILLY CANADA INC
Country
Canada (CA)
ATC code
A10AB04
ATC class
Insulin lispro
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

434 interactions on record for insulin lispro.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check insulin lispro against other medicinesHow interaction checks work

Insulin lispro · interactions on record

434 records

  • 15 severe
  • 368 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin lispro in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin lispro products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Bysumlog, Humalog
  • Liechtenstein · Bysumlog, Humalog
  • Norway · Bysumlog, Humalog

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c082027d-2ac0-44b1-ae4a-3e589ef27bf1
GET /v1/drugs/c082027d-2ac0-44b1-ae4a-3e589ef27bf1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02439611",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "SUBCUTANEOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "A10AB04",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "92402",
  "strengths": [
    "200 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "INSULIN LISPRO"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about insulin lispro.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console